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Introduction: Juvenile idiopathic arthritis is a heterogeneous T cell-mediated autoimmune disease with symptoms
of premature aging of the immune system (immunosenescence). The present work is an investigation of
immunosenescence parameters, such as quantity of naive and CD28- T cells, T cell receptor excision circles, relative
telomere length and alterations of peripheral T cell replication, and was performed via comparison of a case of
acute exacerbation of juvenile idiopathic arthritis against six patients with juvenile idiopathic arthritis with disease
remission and six age-matched healthy donors over a follow-up course of 12 months.
Case presentation: Phenotypical T cell characterization and intracellular interferon γ, tumor necrosis factor α, and
interleukin 2 production were studied in peripheral blood mononuclear cells from seven patients with juvenile
idiopathic arthritis and six healthy control donors, with findings determined by flow cytometry. T cell receptor
excision circles and relative telomere length quantification were performed on deoxyribonucleic acid isolated from
naive (CD4+CD28+CD45RA+) T cells and investigated via reverse transcription polymerase chain reaction. Ki67
expression was studied by immunohistochemistry on naive T cells. The non-parametric Mann-Whitney U test and
Wilcoxon test for two independent groups of variables were used to compare healthy donors with patients with
juvenile idiopathic arthritis. During follow-up, patients with juvenile idiopathic arthritis showed lower total counts of
naive and CD28-expressing T cells compared to healthy donors. Acute exacerbation led to low naive and CD28+ T
cell populations and elevated proportions of Ki67-expressing CD4+ naive T cells. In conditions of exacerbation, T cell
receptor excision circle numbers were in the lower range in patients with juvenile idiopathic arthritis and increased
after follow-up. Healthy donors showed significantly higher relative telomere lengths compared to patients with
juvenile idiopathic arthritis.
Conclusions: This investigation illustrates that the changes in T cell homeostasis in patients with juvenile idiopathic
arthritis may be the result of several mechanisms, such as diminished thymus function and peripheral exertions to
maintain the peripheral T cell pool. The results also demonstrate that hallmarks of immunosenescence such as
decreased naive T cell levels and lower T cell receptor excision circle numbers can only be interpreted together
with replication markers such as relative telomere length or Ki67 expression.
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Juvenile idiopathic arthritis (JIA) is a heterogeneous T cell-
mediated autoimmune disease. Common to all seven sub-
types of JIA, disease onset is prior to the age of 16 years
and is characterized by a chronicity of at least six weeks.
For adult rheumatoid arthritis (RA), it has been suggested
that T cells play an important role in the pathogenesis of
the disease. Patients with RA present with immune system
abnormalities that resemble the typical characteristics of
immune dysfunction described in older patients [1]. Im-
munological investigations of patients with RA have re-
vealed disturbed T cell homeostasis and diminished thymus
output, which was characterized by decreased amounts of
T cell receptor excision circles (TRECs) and compensatory
peripheral T cell proliferation with telomere shortening [2]
and loss of the co-stimulatory molecule CD28, a typical
sign of replicatively stressed cells [3]. Patients with JIA
demonstrate premature immunosenescence of the CD4+
naive T cell pool with age-inappropriate low TREC num-
bers, shortened telomere lengths and increased peripheral
replication of peripheral naive T cells [4]. TRECs are stable
deoxyribonucleic acid (DNA) episomes forming during
T cell receptor rearrangement. TRECs are not replicated
during mitosis and are diluted out during cell divisions.
Therefore, TREC counts in naive T cells are not only recog-
nized as a marker for recent thymic emigrants (RTE), but
are also influenced by peripheral replication of naive T cells
[5]. Telomeres are TTAGGG-rich repeats located at the
ends of chromosomes and play an important role in DNA
replication and preservation of chromosome integrity.
Telomere erosion has been considered a mitotic clock, with
the telomere length approximately reflecting the life history
of divisions of individual cells [6].
The influence of clinical disease activity on these parame-
ters is still unclear in JIA. The present investigation of
immunosenescence parameters was performed via com-
parison of a case of acute exacerbation of JIA against six pa-
tients with JIA with disease remission and six age-matched
healthy donors (HD) over a follow-up course of 12 months.Case presentation
Materials and methods
Study population
Peripheral blood mononuclear cells (PBMCs) were
obtained from seven patients with JIA (all girls), specifically
with extended oligoarticular JIA. All patients were tested
and found to be rheumatoid factor (RF) negative and
anti-nuclear antibody (ANA) positive, and fulfilled the
International League of Associations for Rheumatology
(ILAR) classification for JIA [7]. PMBCs were also obtained
from six age-matched and sex-matched healthy donors
(HD) (Table 1). All donors were recruited at the Depart-
ment of Pediatrics, Medical University Innsbruck.One of the patients with JIA was a 16-year-old girl (pa-
tient 7 in Table 1), with extended oligoarticular JIA (ANA
positive test result, 1:320; RF negative test result) with dis-
ease onset at three years of age. Our patient presented with
acute disease exacerbation at the time of evaluation. She
was classified as in clinical remission off medication for
over 12 months, as according to published criteria for dis-
ease remission [8]. Disease exacerbation at the time of
evaluation was verified by clinical examination (extended
oligoarthritis with painful joints of the upper and lower
extremities) and increased laboratory parameters (C-react-
ive protein level [CRP] 5.14mg/dL; erythrocyte sedimenta-
tion rate [ESR] 99mm/first hour, 152mm/second hour;
ANA 1:640). After acute exacerbation, our patient was
treated with indometacin (2mg/kg/day) and prednisolone
(1mg/kg/day) for four weeks. Methotrexate was adminis-
tered (10mg/m2 body surface/week) orally. Over a six-
month period, our patient showed disease remission on
methotrexate and prednisolone (<0.1mg/kg/day) treatment
(that is, remission on medication) [8]. A 12-month follow-
up sample was taken under conditions of disease remission
off medication for at least five months.
Patients 1 to 6 (see Table 1) were in clinical remission off
medication for at least 12 months [8]. The criteria for dis-
ease remission included the following: no active arthritis,
no fever, no rash, serositis, splenomegaly, or generalized
lymphadenopathy attributable to JIA, no active uveitis, nor-
mal ESR or CRP level, and a physician global assessment of
disease activity indicating clinical disease quiescence. After
12 months of follow-up, patients 1 to 6 were still in remis-
sion off medication [8].
Controls were healthy according to World Health
Organization (WHO) definition. None of the HD had a
personal or family history of inflammatory disease or re-
ceived medications. Unfortunately, HD blood samples were
not collected after 12 months because donors refused to
have samples taken. However, significant changes to the in-
vestigated immunosenescence parameters were not
expected in healthy young individuals during this period of
time. Therefore, recruitment of the original HD group did
not appear to be mandatory to fulfill the scope of the study
and the missing follow-up data for HD were neglected. The
study was performed according to the Declaration of
Helsinki (2000) and approved by the local ethics committee
(Medical University Innsbruck). All patients with JIA and
HD gave their written informed consent to participate in
this study.
Separation of T cell subsets
PBMCs were isolated by using LymphoPrep™ (Axis Shield,
Oslo, Norway) according to the manufacturer’s instructions.
CD4+CD28+CD45RA+ (naive) T cells were separated by
positive selection using CD4, CD45RA, CD28 antibodies la-
beled with magnetic beads and an autoMACS™ with sterile
Table 1 Matching of the juvenile idiopathic arthritis (JIA)
group (patients 1 to 6), our patient with JIA with acute
exacerbation (patient 7), and healthy donors (patients 8
to 13)
Patient Age
(months)
Disease onset
(months)
Disease duration
(months)
1 191 44 147
2 143 44 99
3 161 37 124
4 157 61 96
5 196 42 154
6 173 49 124
7 192 48 144
8 184 - -
9 136 - -
10 156 - -
11 144 - -
12 204 - -
13 172 - -
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of separated CD4+CD28+CD45RA+ T cells was checked
using four-color flow cytometry (FACSCalibur™ flow
cytometer; Becton Dickinson, Oxford, UK) and ranged
from 97 percent to 99 percent.
Quantification of T cell subsets
PBMCs were incubated with monoclonal mouse anti-
bodies (mAbs) specific for CD3, human leukocyte antigen
(HLA)-DR, CD4, CD8, CD28, CD25, CD45RA, CD45RO,
and CD62L labeled with fluorescein isothiocyanate (FITC),
phycoerythrin (PE), peridinin-chlorophyll-protein complex
(PerCP) or allophycocyanin (APC) (all antibodies were
purchased from BD Pharmingen™, San Jose, CA, USA) for
20 minutes at room temperature in the dark. After incuba-
tion, red blood cell lysis was performed with FACS™ Lysing
Solution (BD Pharmingen™, San Jose, CA, USA). Subse-
quently, cells were washed twice with phosphate-buffered
saline and fixed with 2 percent paraformaldehyde. All
analyses were performed using a FACSCalibur™ flow
cytometer utilizing CellQuest™ software (DB Pharmingen™,
San Jose, CA, USA). According to phenotypic CD
markers, CD28+CD45RA+ and CD45RA+CD62L+ T cells
were characterized as naive, CD45RO+ as memory T cells
and CD4+CD25+CD62L+ as regulatory T cells.
Quantification of TREC numbers
TREC numbers within CD4+CD28+CD45RA+ T cells
were assessed. DNA was extracted from separated
CD4+CD28+CD45RA+ T cells using QIAampW DNA
Mini Kit (Qiagen, Chatsworth, CA, USA). Signal-joint
TREC concentrations were determined by quantitativeSYBRW Green real-time polymerase chain reaction (PCR)
based on the coding TREC sequence using an iCycler iQ™
Real-Time Quantitative PCR Detection System (Bio-Rad
Laboratories, Hercules, Canada). We designed primers to
amplify a DNA fragment of 82bp across the remaining re-
combination sequence δrec/ψalpha (5’-CACATCCCTTT
CAACCATGCT-3’ and 5’-GCCAGCTGCAGGGTTTAG
G-3’). For quantification we used the internal standard as
previously described [9]. To avoid bias by different num-
bers of naive T cells, TRECs were calculated in relation to
CD4+CD28+CD45RA+ T cell numbers.
Telomere length analysis
Determination of relative telomere length (RTL) was
performed in separated CD4+CD28+CD45RA+ T cells by
calculating the ratio of a quantitative PCR reaction product
from the same sample using specific primers for telomeres
and a single copy gene. Quantitative PCR is the method of
choice for determining telomere lengths in small extract-
able quantities of DNA, as was the case in our study.
Ki67 staining
Naive T cells in the cell cycle were identified by expression
of the Ki67 nuclear antigen. Determination of Ki67 ex-
pression on CD4+CD28+CD45RA+ T cells was performed
by cytospin preparation (Shandon CytospinW 4, Waltham,
MA, USA) of 5×103 CD4+CD28+CD45RA+ T cells and
permeabilized with TRITON™ X-100 (Sigma-Aldrich,
St Louis, MO, USA). Immunohistochemistry was under-
taken in a fully automated NexESW IHC system (Ventana
Medical Systems, AZ, USA). For microscopic orientation
counterstaining was performed with Hematoxylin
Counterstain and Bluing Reagent (Ventana Medical Sys-
tems, AZ, USA). Stained sections were examined by two
independent investigators (MP and AB) by light micros-
copy (Eclipse 800, Nikon, Japan). Percentages of Ki67+
cells were calculated per total CD4+CD28+CD45RA+
T cell counts on each cytospin preparation.
Intracellular cytokine production
For intracellular staining, cells were stimulated with
25ng/mL phorbol 12-myristate 13-acetate and 1μg/mL
ionomycin in the presence of 10μg/mL brefeldin A for
four hours (Sigma-Aldrich, Munich, Germany). After
cell surface staining for CD4, CD8 and CD45RA with
subsequent fixation and permeabilization, cells were
stained with FITC-conjugated anti-interferon (IFN)γ,
anti-tumor necrosis factor (TNF)α, and anti-interleukin
(IL)-2, antibodies or control immunoglobulin (R&D
Systems Inc., Minneapolis, MN, USA). For intracellular
cytokine staining, additional markers for naive T cells,
such as CD28, could not be implemented because of
technical limitations. Final fixation was achieved using
1 percent cell fix (Becton Dickinson, San Diego, CA,
Almanzar et al. Journal of Medical Case Reports 2013, 7:135 Page 4 of 8
http://www.jmedicalcasereports.com/content/7/1/135USA). Data were analyzed using WinMDI software
(V. 2.8, Joseph Trotter, Scripps Research Institute,
La Jolla, CA, USA).
Statistical analysis
The non-parametric Mann-Whitney U test for two inde-
pendent groups of variables was used to compare HD with
patients with JIA (SPSS V.15.0; SPSS Inc., Chicago, IL,
USA). The non-parametric Wilcoxon test for pair differ-
ences was used for two dependent groups of variables (JIA
and JIA follow-up). A p-value of <0.05 was considered
significant.
Results
Lower naive T cell counts in patients with JIA
CD45 isoforms and CD28 surface marker expression were
used to define naive and memory T cells in peripheral
CD4+ and CD8+ subsets in our patient with acute exacer-
bation, patients with JIA in remission at the beginning and
over a 12-month follow-up study and age-matched HD
(Tables 1 and 2). Lack of CD28 expression on both CD4+
and CD8+ T cells has been associated as a biological indi-
cator of aging of the immune system upon continuous
antigen stimulation and subclinical inflammation [10] and
was therefore included in the study. There was a signifi-
cantly lower number of CD4+CD28+CD45RA+ T cells
(P=0.02) and CD8+ CD28+CD45RA+ T cells (P=0.04)
(Table 2) in the follow-up evaluation of patients with JIA
compared with HD (Figure 1A, Table 2). Patients with JIA
showed significantly lower numbers of CD4+CD28-ex-
pressing cells as compared with HD (P=0.01), and theTable 2 T cell subset counts in patients with juvenile idiopath
Patient with JIA
with acute
exacerbation/
follow-up
JIA group (n=6)
CD3+ 1.1/1.3 1.73±0.68 (1.60; 1.10 to 2.80)
CD3+HLA-DR+ 0.06/0.03 0.09±0.01 (0.09; 0.08 to 0.11)
CD3+CD4+ 0.72/0.93 0.94±0.48 (0.79; 0.55 to 1.83)
CD4+CD25+CD62L+ 0.12/0.04 0.19±0.18 (0.15; 0.03 to 0.52)
CD4+CD28+ 0.20/0.31 0.90±0.46 (0.76; 0.53 to 1.73)***
CD4+CD28+CD45RA+ 0.15/0.16 0.33±0.24 (0.25; 0.001 to 0.62)
CD4+CD45RA+CD62L+ 0.22/0.04 0.39±0.24 (0.43; 0.001 to 1.14)
CD4+CD45RO+ 0.12/0.15 0.08±0.07 (0.06; 0.01 to 0.22)
CD3+CD8+ 0.34/0.37 0.50±0.19 (0.49; 0.27 to 0.73)
CD8+CD28+ 0.28/0.32 0.41±0.16 (0.41; 0.18 to 0.64)
CD8+CD28+CD45RA+ 0.30/0.25 0.57±0.51 (0.43; 0.01 to 1.44)
CD8+CD45RA+CD62L+ 0.07/0.09 0.31±0.25 (0.20; 0.05 to 0.53)***
CD8+CD45RO+ 0.38/0.90 0.23±0.12 (0.23; 0.03 to 0.41)**
Total counts ×103 cells/μL are given as mean±standard deviation (median; range). S
are indicated with **p<0.025, ***p<0.01. Significant differences between JIA follow-
differences between JIA group and HD are indicated with xxp<0.025.difference was more pronounced after 12 months
(P=0.004) (Figure 1B). The same effect was also observed in
CD8+CD28-expressing cells (P=0.02) (Table 2). In the acute
exacerbation stage in our patient (patient 7), this effect was
more dramatic. Our patient showed low numbers of
CD45RA-expressing and CD28-expressing T cells at the
beginning and at follow-up (Figure 1A,B), and also showed
lower percentages of CD28+ T cells within the CD4+ T cell
pool at acute exacerbation (27.8 percent) and at follow-up
(33.3 percent) compared to patients with JIA (mean 95.7
percent; at follow-up 96.6 percent) and HD (96.9 percent).Increased replication of CD4+ naive T cells in acute
exacerbation of JIA
Reduction of TRECs is a function of both thymic output of
RTE and of replication of peripheral naive T cells [6].
Therefore, TREC numbers should be interpreted in correl-
ation with replicative markers, such as telomere length or
Ki67 expression. Proliferative status, relative telomere
length (RTL), and TRECs were assessed in peripheral blood
samples from our patient with acute exacerbation, patients
with JIA, and HD.
An increased proportion of Ki67-expressing CD4+CD28
+CD45RA+ naive T cells (1.68 percent) and a relatively low
proportion of replicating cells after remission (0.15 percent)
was determined in our patient with acute exacerbation
(Figure 2A). In contrast, in patients with JIA (patients 1 to
6 in Table 1), the proportion of replicating cells (Ki67+) in-
creased after 12 months (0.43±0.40 percent to 0.66±0.41
percent after follow-up) (Figure 2A). Relative low Ki67ic arthritis (JIA) and healthy donors (HD)
JIA follow-up (n=6) HD (n=6)
1.04±0.49 (0.98; 0.51 to 1.72)++ 2.18±0.36 (2.0; 1.90 to 2.70)
0.09±0.05 (0.11; 0.03 to 0.16) 0.13±0.03 (0.12; 0.11 to 0.19)xx
0.59±0.31 (0.62; 0.24 to 0.96)++ 1.31±0.35 (1.24; 0.88 to 1.84)
0.14±0.09 (0.13; 0.05 to 0.26) 0.25±0.08 (0.23; 0.15 to 0.35)
0.57±0.29 (0.62; 0.23 to 0.90)+++ 1.27±0.34 (1.22; 0.84 to 1.78)xx
0.31±0.15 (0.35; 0.13 to 0.46)++ 0.49±0.012 (0.45; 0.34 to 0.63)xx
0.19±0.08 (0.19; 0.09 to 0.28) 0.34±0.32 (0.16, 0.19 to 0.61)
0.22±0.13 (0.23; 0.07 to 0.38) 0.15±0.11 (0.17; 0.001 to 0.29)
0.41±0.18 (0.37; 0.21 to 0.65)++ 0.78±0.14 (0.76; 0.63 to 0.96)
0.31±0.15 (0.26; 0.17 to 0.51)++ 0.61±0.11 (0.64; 0.47 to 0.75)
0.29±0.13 (0.27; 0.16 to 0.47)+ 0.66±0.24 (0.63; 0.41 to 1.06)
0.19±0.07 (0.16; 0.12 to 0.29) 0.32±0.29 (0.13; 0.19 to 0.52)
0.70±0.30 (0.61; 0.30 to 1.13) 0.41±0.25 (0.42; 0.001 to 0.69)
ignificant differences between patients with JIA (JIA group) and JIA follow-up
up and HD are indicated with +p<0.05, ++p<0.025, +++p<0.01. Significant
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in HD (Figure 2A).
With regard to TREC numbers, no changes were ob-
served in patients with JIA in remission at first evaluation
(1649±586 per 104 CD4+CD28+CD45RA+ T cells) or after
12 months (1424±384 per 104 CD4+CD28+CD45RA+
T cells) (Figure 2B), while TREC number dramatically
increased in our patient with acute exacerbation after 12
months (exacerbation: 737 per 104 CD4+CD28+CD45RA+
T cells; follow-up: 3749 per 104 CD4+CD28+CD45RA+
T cells) (Figure 2B). Slightly higher TREC numbers
were detected in naive T cells (3685±2264 per 104
CD4+CD28+CD45RA+ T cells) in HD (Figure 2B).
Moreover, our patient (patient 7 in Table 1) during exacer-
bation and after 12 months showed lower RTL (during ex-
acerbation: 0.67; follow-up: 0.37) compared to patients with
JIA (patients 1 to 6 in Table 1) in remission (0.90±0.12; JIA
follow-up: 0.69±0.38) (Figure 2C). Significantly higher RTL
were determined in HD (2.45±1.27; P=0.04) (Figure 2C).
Disturbed cytokine production in our patient with acute
exacerbation of JIA
TNFα, IFNγ, and IL-2 production was determined in
CD45RA-expressing and CD45RO-expressing CD4+ and
CD8+ T cells at acute exacerbation of our patient by intra-
cellular cytokine analysis. No significant differences were
determined in the cytokine production in the four T cell
subpopulations in patients with JIA or HD (Table 3). How-
ever, a higher proportion of IL-2 producing CD45RA+ and
CD45RO+ T cells were detected in patients with JIA com-
pared with the HD group (Table 3). Remarkable increased
proportions of TNFα, IFNγ and IL-2 producing CD45RO+(A)
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Figure 1 Lower naive T cell counts in patients with Juvenile Idiopathi
cell counts (B) in patients with JIA are shown. Closed squares show patient
after 12 months, X indicates our patient with JIA with acute exacerbation, a
considered significant.T cells were determined in our patient with acute exacerba-
tion (Table 3).
Discussion
Our patient’s case gives an impression of disturbed periph-
eral CD4+CD28+CD45RA+ T cell homeostasis under the
condition of acute disease exacerbation and underlines the
importance of considering disease activity when evaluating
immunological aging markers. Although limited by a small
number of patients with JIA, the present study corroborates
the fact that markers of immunosenescence such as de-
creased naive T cells and lower TREC numbers can only be
interpreted correctly together with replication markers such
as telomere length or Ki67 expression. Intracellular cyto-
kines may be supportive parameters but are shown to be
too variable to act as reliable markers to study clinical
aspects of disease activity.
Loss of CD28 expression has been suggested as a marker
of replicative senescence for T cells [10]. A clonal expansion
of CD8+CD28- T cells was found in older people [10] and
individuals with RA [3]. The data from the follow-up
cohort confirm the findings of an accelerated decrease of
naive T cells in patients with JIA with advancing chrono-
logical age [4], which was also demonstrated for patients
with RA [1,2]. However, this comparison is limited as we
were not able to provide follow-up data of the HD group.
Although acute exacerbation did not change the total
counts of CD4+CD28+CD45RA+ or total CD28-expressing
T cells, percentages of CD28-expressing CD4+ T cells were
significantly decreased in our patient with acute exacerba-
tion, whereas percentages of CD28-expressing CD4+ T cells
were different between JIA follow-up and HD.(B)
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Figure 2 Proliferative measures in Juvenile Idiopathic Arthritis (JIA) patients. Ki67-expressing CD4+CD28+CD45RA+ T cells (A), T cell receptor
excision circles (TRECs) (B), and relative telomere length (RTL) (C). Closed squares show patients with juvenile idiopathic arthritis (JIA), open
squares JIA follow-up after 12 months, X indicates our patient with JIA with acute exacerbation, and closed circles show healthy donors (HD). A
p-value of <0.05 was considered significant.
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peripheral T cell turnover under the condition of acute dis-
ease exacerbation. TREC numbers were lower in patients
with JIA compared to HD and unaltered by follow-up in
the JIA group. These results corroborate the findings that
patients with JIA show age-inappropriate lower TREC
numbers but with no correlation with chronological age
[4]. Our patient with acute exacerbation showed relatively
low TREC numbers during the acute exacerbation period
compared to patients with JIA with disease remission. In
our patient with acute exacerbation, enhanced TREC num-
bers and even higher TREC numbers than the other
patients with JIA were found after disease remission,
suggesting recovery of thymus function after successful
treatment. This is in accordance with findings in children
and younger adults with acquired immunodeficiency syn-
drome (AIDS) under highly active anti-retroviral therapy
(HAART) [11] in whom recovery to higher levels thanbefore HAART was found. The study suggested that on-
going production of naive CD4+ T cells in the thymus is
most active during the earlier stages of HAART and de-
clines later during HAART. However the precise timing of
when children show maximum thymic output during
HAART remains unclear. An increase in the fraction of
TREC+ T cells per naive T cell, which was equivalent to a
faster growth of TREC+ T cells versus total naive T cells
was also found for CD4+ T cells following initiation of
HAART [12]. When discussing the TREC dynamics in our
patient with acute exacerbation, we cannot sufficiently an-
swer the question as to whether our patient already had
low TREC numbers before exacerbation, as found in chil-
dren with AIDS before initiation of HAART.
However, TREC numbers are also influenced by periph-
eral proliferation and, therefore, dilution of TRECs may be
caused by increased replication of peripheral CD4+ naive
T cells, which may be confirmed by enhanced Ki67-
Table 3 Intracellular cytokine production during acute exacerbation
Patient with JIA with
acute exacerbation
JIA group (n=6) HD group (n=6)
TNFα (percentage of CD4+CD45RA+) 6.09 6.99±2.52 (6.37; 4.62 to 10.43) 6.26±4.60 (4.47; 1.82 to 12.9)
IFNα (percentage of CD4+CD45RA+) 19.63* 2.77±1.24 (2.60; 1.15 to 4.39) 4.04±2.21 (3.52; 1.39 to 7.49)
IL-2 (percentage of CD4+CD45RA+) 53.74 37.63±31.49 (28.65; 5.53 to 81.25) 14.68±9.79 (14.54; 3.12 to 28.56)
TNFα (percentage of CD4+CD45RO+) 41.99* 21.11±9.17 (21.18; 7.74 to 34.36) 18.19±8.79 (15.38; 11.31 to 34.69)
IFNα (percentage of CD4+CD45RO+) 41.23* 10.05±4.09 (10.12; 4.52 to 14.46) 13.30±6.07 (12.08; 8.21 to 24.21)
IL-2 (percentage of CD4+CD45RO+) 79.77 50.09±30.69 (41.09; 15.65 to 90.03) 31.01±22.65 (24.37; 8.56 to 60.41)
TNFα (percentage of CD8+CD45RA+) 8.19 7.05±3.64 (6.40; 2.70 to 21.30) 5.39±4.04 (4.35; 1.44 to 11.80)
IFNγ (percentage of CD8+CD45RA+) 18.21 11.27±8.12 (8.19; 4.49 to 24.05) 8.68±5.13 (6.86; 4.61 to 18.20)
IL-2 (percentage of CD8+CD45RA+) 54.61* 25.73±26.00 (16.35; 6.63 to 17.52) 12.49±9.45 (8.44; 3.99 to 25.89)
TNFα (percentage of CD8+CD45RO+) 68.22* 24.04±10.02 (27.43; 11.44 to 33.10) 22.98±9.35 (22.6; 12.27 to 35.64)
IFNγ (percentage of CD8+CD45RO+) 83.67* 28.26±19.57 (27.43; 2.63 to 50.26) 34.77±17.44 (33.33; 9.14 to 61.50)
IL-2 (percentage of CD8+CD45RO+) 73.48* 34.82±15.52 (31.53; 17.52 to 58.08) 23.84±22.63 (12.86; 4.58 to 60.27)
Total counts ×103 cells/μL are given as mean±standard deviation (median; range). Values from our patient with JIA with acute exacerbation (patient 7) below or
above the range found in the JIA group are indicated with *.
HD, healthy donors; IFN, interferon; IL, interleukin; JIA, juvenile idiopathic arthritis; TNF, tumor necrosis factor.
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tient. Additionally, decreased thymic output will induce
compensatory autoproliferation, a process that contributes
to TREC dilution. Chronic T cell stimulation induces in-
creased T cell turnover in patients with JIA, as demon-
strated by age-inappropriate short T cell telomere lengths
in patients with JIA. Age-inappropriate thymic involution
and increased peripheral T cell turnover may each contrib-
ute to the lower TREC numbers observed in patients with
JIA. These data highlight the pitfalls of interpretation of
TREC data [13], therefore, replication markers such as
Ki67 expression and RTL were considered in our study.
TREC numbers were calculated to CD4+ naive T cell
counts, the latter unaltered by acute exacerbation. In view
of these results it has to be considered that the peripheral
naive T cell pool consists of two subsets of cells, namely
RTE and peripheral replicating cells. Increased replication
of naive T cells may be the crucial factor in acute exacer-
bation and disease activity. However, despite high replica-
tion activity increased amounts of naive T cells were not
found in the peripheral blood samples from our patient
with acute exacerbation, possibly due to accumulation in
other compartments, (for example, the inflamed joints).
Maturation of naive T cells to CD45RO+ memory T cells
may be a possible explanation for disappearance of periph-
eral blood naive T cells despite increased replicative activ-
ity. This was also assumed for a model describing naive
T cell dynamics in children and younger adults receiving
HAART [12]. Increased priming into memory T cells may
be also true for our patient with acute exacerbation, who
showed markedly increased CD8+CD45RO+ counts. Dur-
ing remission, enhanced thymus output of RTE, decreased
replication activity of naive T cells, priming into memory
T cells and/or depletion of peripheral blood naive T cellsby accumulation in other sites may have contributed to
the increased TREC numbers in naive T cells seen in the
12-month follow-up of our patient.
There was a tendency to lower RTL in the 12-month
follow-up of patients with JIA compared to HD. Although
limited by missing follow-up data from HD, these results
fit with the tendency of increased Ki67-expressing CD4+
naive T cells in patients with JIA compared to HD [4].
Telomeric erosion was also clearly accelerated in patients
with RA [2], which was explained as a consequence of
compensatory cell renewal.
Cytokines have been implicated in driving homeostatic
T cell replication. Their most likely disease-related pro-
duction could enhance T cell proliferation and exhaust the
replicative potential [14]. JIA has been associated with
high serum or intra-articular levels of proinflammatory cy-
tokines such as IL-6, IL-1α, IL-1β or TNFα [15]. In fact,
our study demonstrated an increase in the levels of TNFα,
IFNγ and IL-2 in both CD45RA+ and CD45RO+, CD4/
CD8 T cell subpopulations in patients with JIA. Moreover,
high levels of these pro-inflammatory cytokines were ob-
served in our patient with acute exacerbation during the
exacerbation state, suggesting a Th1 cytokine-driven
mechanism supported by an accumulation of CD45RO+
memory T cells and the reduction in the naive T cell popu-
lation. Interestingly, classical cytokines for memory and ef-
fector T cell responses, such as TNFα and IFNγ, were
increased in the CD45RA+ T cells. One may ask the ques-
tion whether CD45RA+ alone is a reliable marker for naive
T cells, as effector T cells also express CD45RA but lose
CD28 surface expression. For this reason it may be more
likely that the proportions of increased TNFα and IFNγ
within the CD45RA+ T cell pool are predominately caused
by activation of effector T cells.
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Our patient’s case supports the notion that changes in
T cell homeostasis in JIA are down to the effect of sev-
eral mechanisms such as diminished thymus function
and peripheral exertions to maintain the peripheral
T cell pool [4]. The findings also demonstrate that quan-
titative T cell measurements or TRECs alone are insuffi-
cient to explain the immunological process in acute
exacerbation of the disease or in remission. The results
should only be interpreted together with data on replica-
tion. As, for the most part, the interpretation of the al-
terations found in our patient’s case remains speculative,
there is increased demand for a prospective evaluation
of the influence of disease activity as well as of therapy
on thymus function and reconstitution of the naive
T cell immune system in JIA.
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